Current Drug Targets

Journal Title：Current Drug Targets

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

《当前药物靶点》旨在报道药物化学和分子药物靶点药理学方面的最新和最杰出的进展，例如疾病特异性蛋白质、受体、酶、基因。

《当前药物靶点》出版由该领域领导者撰写的客座编辑专题，涵盖一系列药物靶点的当前主题。该期刊还接受发表简短和完整的评论文章以及药物临床试验研究。

随着用于药物发现的新型人类药物靶点的发现、鉴定、表征和验证不断增长；这本期刊是所有参与药物发现和开发的制药科学家的必读读物。

Current Drug Targets创刊于2000年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵盖医学 - 药学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 一般,3-8周 ，影响因子指数3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。